Delivery Order SPE2DB20D3101-SPE2DB25FRTF2
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $1,180.03, represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order is...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $2,076.50, represents a competitive award with no set-aside designation and is scheduled for completion by August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5 gram units. This contract, valued at $5,328.34, was competitively awarded without a set-aside designation and carries a firm fixed price structure. The award was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This competitive, non-set-aside contract has a ceiling value of $2,675.15 and was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units under a firm fixed-price contract valued at $1,716.53. The order was competitively awarded without a set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Erythromycin 0.5% Eye Ointment under contract number 4568964193. This firm fixed-price delivery order, valued at $2,475.20, represents a non-set-aside competitive award with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5GM units, with a ceiling value of $1,075.00. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the contractor's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through December 2026. The place of...
- The Defense Logistics Agency awarded a $4,755.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% eye ointment, with performance at the contractor's Conshohocken, Pennsylvania facility and an ultimate completion date of August 26, 2025. This non-competitive, non-set-aside delivery order was issued on August 25, 2025, and represents a discrete pharmaceutical supply requirement under the federal medical procurement framework supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $3,960.32 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the company's Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $1,980.16 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment (UDGM) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's larger...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRTF2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units, with a contract ceiling value of $1,460.44 and an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities. The DLA Troop Support Medical maintains this prime vendor relationship as part of its strategic approach to pharmaceutical procurement for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/21/25 |